About IMMUNARTES, LLC
Immunartes is developing therapies that neutralize immune evasion to restore host defense and prevent serious S. aureus disease. The company focuses on durable immunity and immediate protection through vaccine and mAb programs.
Developing therapies that neutralize immune evasion mechanisms of S. aureusDesigning vaccine modalities for durable, population-scale preventionCreating mAb modalities for immediate protection in high-risk clinical settingsConducting preclinical discovery and IND-enabling studies
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| ADVANCED DEVELOPMENT OF A VACCINE CANDIDATE FOR STAPHYLOCOCCUS AUREUS INFECTION AND COLONIZATION. | Department of Health and Human Services | $4.7M |
Teaming History
Prime contractors IMMUNARTES, LLC has worked under:
- Trustees Of Boston University — 3 subcontract(s)
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to IMMUNARTES, LLC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.